|
2025
|
G/S
|
Chemical agents for laboratory use, in particular nucleic acids, peptides and proteins; chemical ... |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer |
|
|
Invention
|
Trans-replicating rna.
The present invention generally relates to systems and methods suitable f... |
|
|
Invention
|
Particles, compositions and methods. The present disclosure relates generally to nucleic acid-lip... |
|
|
Invention
|
Methods for identifying exhausted t cells and t-cell receptors thereof. The present disclosure pr... |
|
|
Invention
|
Compositions and methods for producing engineered immune cells. The present disclosure provides c... |
|
|
Invention
|
Soluble tcrs and methods of use thereof. The present disclosure provides a therapy with soluble T... |
|
|
Invention
|
Repression of cargo expression. The present application relates to an isolated nucleic acid compr... |
|
|
Invention
|
Rna compositions for delivery of orthopox antigens and related methods. The present disclosure pr... |
|
|
Invention
|
Combination therapy comprising therapeutic rna cancer vaccines and anti-ctla4 antibodies for canc... |
|
|
Invention
|
Cancer vaccines. The present disclosure provides compositions (e.g., pharmaceutical compositions)... |
|
|
Invention
|
Cytotoxic polynucleotides, particles containing the cytotoxic polynucleotides and uses thereof. T... |
|
|
Invention
|
Interleukin 18 receptor agents for specific activation of immune effector cells. The disclosure p... |
|
|
Invention
|
Systems and methods for machine learning-based genome annotation.
The present disclosure, among ... |
|
|
Invention
|
Systems and methods for multimodal conversational agents for biological sequence analysis. Provid... |
|
|
Invention
|
Systems and methods for machine learning-based genome annotation. The present disclosure, among o... |
|
|
Invention
|
Systems and methods for multimodal conversational agents for biological sequence analysis.
Provi... |
|
|
Invention
|
Combination therapy comprising a pd-1/pd-l1 and vegf/vegfr binding agent and a chemotherapy for c... |
|
|
Invention
|
Antibodies capable of binding to ox40, variants thereof and uses thereof.
The present invention ... |
|
|
Invention
|
Coronavirus vaccine. This disclosure relates to the field of RNA to prevent or treat coronavirus ... |
|
|
Invention
|
Compositions and methods. An aqueous dispersion having an aqueous mobile phase and a dispersed ph... |
|
|
Invention
|
Methods of treating urothelial carcinoma with a pd-1 axis binding antagonist and an rna vaccine. ... |
|
|
Invention
|
Rna encoding an immune inhibitory il-1 family member. The present invention provides an isolated ... |
|
2024
|
Invention
|
Methods for predicting the usefulness of disease specific amino acid modifications for immunother... |
|
|
Invention
|
Anti-ctla-4 antibody for treatment of patients with prostate cancer and combination therapy with ... |
|
|
Invention
|
Cfc1 binding molecule. The present invention relates to a binding molecule comprising a CFC1 bind... |
|
|
Invention
|
Anti-bacterial polypeptides. The present disclosure relates to mutated polypeptides comprising a ... |
|
|
Invention
|
Method and kit for measuring and reducing protein impurities. The present invention relates to a ... |
|
|
Invention
|
Methods for predicting the usefulness of proteins or protein fragments for immunotherapy.
The pr... |
|
|
Invention
|
Combination therapy comprising a bispecific anti-vegf-a and anti-pd-l1 antibody and a chemotherap... |
|
|
Invention
|
Formulation for administration of rna.
The present invention relates to compositions comprising ... |
|
|
Invention
|
Coronavirus vaccine.
This disclosure relates to the field of RNA to prevent or treat coronavirus... |
|
|
Invention
|
Methods and compositions for stimulating immune response. The present invention relates to method... |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
G/S
|
Pharmaceutical preparations; vaccines. |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
G/S
|
Downloadable computer software used for biotechnology research and development; downloadable comp... |
|
|
G/S
|
Database management; data management; data processing; data management services; compilation of d... |
|
|
G/S
|
Computer software; computer software comprising algorithms for the selection of pharmaceutical re... |
|
|
G/S
|
Databases; database engines; data processing software; data management software; data mining soft... |
|
|
Invention
|
Antibody-drug conjugate. The present invention relates to an antibody-drug conjugate that compris... |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
G/S
|
Pharmaceuticals; vaccines. |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer |
|
2023
|
Invention
|
Glycolipid compositions. Provided herein are particles and compositions comprising one or more gl... |
|
|
G/S
|
Chemical products for medical and veterinary purposes;
medical and pharmaceutical preparations. ... |
|
|
G/S
|
Chemical preparations for medical and veterinary purposes, namely, for neuroregeneration and the ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and... |
|
|
Invention
|
Rna compositions for delivery of monkeypox antigens and related methods.
The present disclosure ... |
|
|
Invention
|
Binding agents capable of binding to cd27 in combination therapy.
The present invention provides... |
|
|
Invention
|
Replicon compositions and methods of using same for the treatment of diseases.
The present inven... |
|
|
Invention
|
Nucleic acid compositions comprising a multivalent anion, such as an inorganic polyphosphate, and... |
|
|
G/S
|
Pharmaceutical products for treatment of cancer |
|
2022
|
Invention
|
Lipid-based formulations for administration of rna.
The present disclosure relates to compositio... |
|
|
G/S
|
Personal development by means of training and further training for doctors and scientists in the ... |
|
|
Invention
|
Methods for determining mutations for increasing modified replicable rna function and related com... |
|
|
Invention
|
Modified replicable rna and related compositions and their use.
The present invention relates to... |
|
|
Invention
|
Therapeutic rna for lung cancer.
This disclosure relates to the field of RNA to treat lung cance... |
|
|
Invention
|
Treatment involving non-immunogenic rna for antigen vaccination and pd-1 axis binding antagonists... |
|
|
Invention
|
Potency assay for therapeutic potential of coding nucleic acid.
The invention provides potency a... |
|
|
G/S
|
Transportable buildings of metal, namely, modular containers; transportable buildings of metal, n... |
|
|
G/S
|
Transportable buildings of metal; transportable buildings of metal for the manufacture and fillin... |
|
|
G/S
|
Transportable buildings of metal; transportable buildings of
metal for the manufacture and filli... |
|
2021
|
G/S
|
Chemicals for use in pharmaceutical industry;
Active chemical ingredients for use in manufacture... |
|
|
G/S
|
Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture ... |
|
|
Invention
|
Therapeutic rna for hpv-positive cancer.
This disclosure relates to the field of therapeutic RNA... |
